Demographic and clinical characteristics of included patients (n = 174)
Demographics/Characteristics | |
Age (mean) (yr) | 73.35 (SD, 14.33) |
Male (No.) (%) | 74 (42.5) |
NIHSS (mean)a | 14.29 (SD, 6.46) |
Time from stroke to imaging in minutes (mean) | 166 (SD, 144.6) |
Median; Q1–Q3; (min–max) | 115.8; 66–231; 16.8–823.8 |
Stroke onset (No.) (%) | |
Witnessed | 136 (78.2) |
Wake-up | 38 (21.8) |
Most proximal intracranial occlusion (No.) (%) | |
ICA | 40 (23.0) |
M1 | 95 (54.6) |
M2 | 39 (22.4) |
Tandem carotid occlusion (No.) (%) | 41 (23.6) |
Smoking status (No.) (%) | |
Never smoked | 101 (58.7) |
Active | 29 (16.7) |
Former | 23 (13.2) |
Unknown | 21 (12.1) |
Drugs (No.) (%) | |
Anticoagulants | 17 (9.8) |
Antiplatelets | 61 (35.1) |
Antihypertensive | 111 (63.8) |
Diabetes | 26 (14.9) |
Cholesterol | 72 (41.4) |
Treatment received | |
IVT only (No.) (%) | 34 (19.5) |
Endovascular therapy only (No.) (%) | 34 (19.5) |
IVT+endovascular therapy (No.) (%) | 71 (40.8) |
None (No.) (%) | 35 (20.1) |
ASPECTS (No.) (%) | |
6–10 | 155 (89.1) |
0–5b | 19 (10.9) |
Collateral status (No.) (%) | |
4–5 | 81 (46.6) |
2–3 | 82 (47.1) |
0–1c | 11 (6.3) |